Brief: Crossject Reports H1 Operating Income Up At EUR 7.9 Million
26/09/2023 16:57
Sept 26 (Reuters) - Crossject SA 74C.F :
* H1 OPERATING INCOME EUR 7.9 MILLION VERSUS EUR 3.4 MILLION
YEAR
AGO
* CASH POSITION OF EUR 5,391,000 AS OF JUNE 30, 2023
* CONFIDENT TO DELIVER ON OUR LONG-TERM STRATEGIC OBJECTIVES
Source text for Eikon: ID:nGNE9BjVfl
Further company coverage: 74C.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure